Enlivex director reports initial ENLV share and option stake

Enlivex Ltd. director Roger Pomerantz filed an initial ownership report showing his current equity position.

Rhea-AI Filing Summary

Enlivex Ltd. director Roger Pomerantz filed an initial ownership report showing his current equity position. He holds options to acquire 150,000 ordinary shares at an exercise price of $5.967 per share, vesting annually over four years beginning on November 17, 2023, and directly owns 2,480 ordinary shares.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Pomerantz Roger

Role Director

Type	Security	Shares	Price	Value
holding	Option (right to buy)	--	--	--
holding	Ordinary Shares, par value NIS 0.40 per share	--	--	--

Holdings After Transaction: Option (right to buy) — 150,000 contracts (Direct); Ordinary Shares, par value NIS 0.40 per share — 2,480 shares (Direct)

Footnotes (1)

1. F1. The option vests ratably on an annual basis for 4 consecutive years beginning on November 17, 2023.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Roger Pomerantz’s Form 3 filing for ENLV show?

The Form 3 filing shows Roger Pomerantz’s existing equity holdings in Enlivex Ltd. He reports options over 150,000 ordinary shares and direct ownership of 2,480 ordinary shares, providing a baseline of his stake as a company director.

How many Enlivex (ENLV) options does Roger Pomerantz hold?

Roger Pomerantz holds options to acquire 150,000 Enlivex ordinary shares. These options have an exercise price of $5.967 per share and expire on November 17, 2032, establishing a long-dated incentive position tied to the company’s share performance.

What is the vesting schedule of Roger Pomerantz’s ENLV stock options?

The options held by Roger Pomerantz vest ratably on an annual basis over four consecutive years. Vesting began on November 17, 2023, meaning a quarter of the 150,000 underlying shares becomes exercisable each year during the four-year period.

Does the ENLV Form 3 show any recent insider buying or selling by Roger Pomerantz?

The Form 3 discloses holdings rather than recent trades. It reports Roger Pomerantz’s existing options and share ownership, with transaction codes marked as holdings and no buy or sell transactions indicated in the summarized data for this initial ownership report.

How many Enlivex (ENLV) ordinary shares does Roger Pomerantz own directly?

Roger Pomerantz directly owns 2,480 Enlivex ordinary shares. This direct stake is separate from his options to acquire additional shares and reflects his current common equity position as reported in the initial Form 3 ownership statement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 07:04 AM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Pomerantz Roger

(Last) (First) (Middle)

14 EINSTEIN STREET

(Street)

NESS ZIONA 7403618

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Enlivex Ltd. [ ENLV ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares, par value NIS 0.40 per share	2,480	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (right to buy)	(1)	11/17/2032	Ordinary Shares, par value NIS 0.40 per share	150,000	$5.967	D

Explanation of Responses:

1. The option vests ratably on an annual basis for 4 consecutive years beginning on November 17, 2023.

Remarks:

See Exhibit 24.1 - Power of Attorney

	/s/ Shachar Shlosberger, Attorney-in-Fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)